Company / Interest Expense per Share
ANAPTYSBIO, INC Interest Expense per Share History
FY2016-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.04
FY2021
5-year range
$0.04 / $0.04
FY2017-FY2021
Trend
-37.2%
vs FY2020
Sector context
#34 of 43
Health Care
What the data says
ANAPTYSBIO, INC's interest expense per share of $0.04 is lower than 79% of companies in the Health Care sector (FY2021). Interest Expense per Share has declined for 5 consecutive years, from $0.17 in FY2016 to $0.04 in FY2021.
Based on SEC 10-K filings.
0.04 in FY2021 with a 5-year CAGR of -26.2%.
Improved from $0.07 to $0.04 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -17.2%
- 5-Year CAGR
- -26.2%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 43This company $0.04 Sector average $18.61
▼
-99.8% below sector average
Key checks
Key Insights
- ANAPTYSBIO, INC's interest expense per share has declined for 5 consecutive years.
- In FY2021, interest expense per share decreased 37.2% year-over-year.
- Ranks #34 out of 43 companies in the Health Care sector.
- Peak interest expense per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.08 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | $0.04 | -37.2% |
| FY2020 | $0.06 | -8.1% |
| FY2019 | $0.07 | -1.5% |
| FY2018 | $0.07 | -61.4% |
| FY2017 | $0.17 | -0.1% |
| FY2016 | $0.17 | -3.7% |
As of FY2021 · SEC 10-K · Updated Jun 30, 2026